| Estimated new cases | |||||
|---|---|---|---|---|---|
| Male | Female | ||||
| Prostate | 233,000 | 27% | Breast | 232,670 | 29% |
| Lung and bronchus | 116,000 | 14% | Lung and bronchus | 108,210 | 13% |
| Colorectum | 71,830 | 8% | Colorectum | 65,000 | 8% |
| Urinary bladder | 56,390 | 7% | Uterine corpus | 52,630 | 6% |
| Melanoma of the skin | 43,890 | 5% | Thyroid | 47,790 | 6% |
| Kidney and renal pelvis | 39,140 | 5% | Non-Hodgkin lymphoma | 32,530 | 4% |
| Non-Hodgkin lymphoma | 38,270 | 4% | Melanoma of the skin | 32,210 | 4% |
| Oral cavity and pharynx | 30,220 | 4% | Kidney and renal pelvis | 24,780 | 3% |
| Leukemia | 30,100 | 4% | Pancreas | 22,890 | 3% |
| Liver and intrahepatic bile duct | 24,600 | 3% | Leukemia | 22,280 | 3% |
| All sites | 855,220 | 100% | All sites | 810,320 | 100% |